在异质图上进行深度多实例学习,用于药物-疾病关联预测
Yaowen Gu1, Si Zheng2, Bowen Zhang3
1Institute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS&PUMC), Beijing, 100020, China; Department of Chemistry, New York University, NY, 10027, USA.
通过使用深度多重实例学习来预测药物疾病关联 (DDAs),MilGNet增强了药物重新定位. 这种新的方法通过从异质网络中的路径实例中学习来提高准确性和可解释性.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 人工智能的人工智能是人工智能.
背景情况:
- 药物重新定位通过确定现有药物的新用途来加速药物发现.
- 目前用于预测药物疾病关联 (DDAs) 的方法往往缺乏对路径实例级学习的端到端框架.
- 在路径实例中利用拓信息可以导致更精确和可解释的DDA预测.
研究的目的:
- 引入MilGNet,这是一个用于药物重新定位的新型深度多个实例学习框架.
- 开发一种端到端的方法,从药物疾病异质网络中的路径实例中学习.
- 为了提高DDA预测的准确性和可解释性.
主要方法:
- MilGNet使用异质图神经网络 (HGNN) 编码器用于药物和疾病节点嵌入.
- 一个伪元路径生成器从药物疾病对 (袋) 创建多个元路径实例.
- 一个双向实例编码器和基于注意力的多尺度预测器精制和汇总实例表示以进行预测.
主要成果:
- 在五个基准数据集中,MilGNet显著超过了十种先进方法.
- 该方法在袋子和实例级别实现了准确和可解释的预测.
- 案例研究表明,MilGNet有潜力识别新的治疗适应症.
结论:
- MilGNet提供了一种强大而可解释的药物重新定位方法.
- 该框架有效地利用拓信息来增强DDA预测.
- MilGNet有可能加速新药疗法的发现.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
相关概念视频
Drug Discovery: Overview
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
